Concepedia

Nuria Gonzalez‐Rojas Guix

NG

Statistics

Publications

3

Citations

47

H-Index

3

Active since

2016

Affiliations

Boehringer Ingelheim (Germany)(Current)

Boehringer Ingelheim (United Kingdom)

Nuria Gonzalez‐Rojas Guix is an author at Boehringer Ingelheim (Germany) specializing in economic evaluation, health services research, and health policy.

Top concepts

Publications per year

2016–2018

3

Publications

3

Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat<sup>®</sup> fixed-dose combination for chronic obstructive pulmonary disease patients in Italy

C Selya-Hammer, Nuria Gonzalez‐Rojas Guix, Michael Baldwin et al. · Therapeutic Advances in Respiratory Disease · 2016 · 17 citations · Full text

Broadening the Perspective of Cost-Effectiveness Modeling in Chronic Obstructive Pulmonary Disease: A New Patient-Level Simulation Model Suitable to Evaluate Stratified Medicine

Martine Hoogendoorn, Isaac Corro Ramos, Michael Baldwin et al. · Value in Health · 2018 · 16 citations · Full text

, , +10

UK-specific cost-effectiveness of tiotropium + olodaterol fixed-dose combination versus other LAMA + LABA combinations in patients with COPD

Abigail Tebboth, Andrew Ternouth, Nuria Gonzalez‐Rojas Guix · ClinicoEconomics and Outcomes Research · 2016 · 14 citations · Full text

1–3 of 3